First American Trust’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

First American Trust’s Portfolio SVNT Stock Details SVNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-30,000	Closed	–	–	148
2020 Q2	$0	Hold	30,000	–	–	﹤0.01%	133
2020 Q1	$0	Hold	30,000	–	–	﹤0.01%	146
2019 Q4	$0	Hold	30,000	–	–	﹤0.01%	150
2019 Q3	$0	Hold	30,000	–	–	﹤0.01%	134
2019 Q2	$0	Hold	30,000	–	–	﹤0.01%	133
2019 Q1	$0	Hold	30,000	–	–	﹤0.01%	120
2018 Q4	$0	Hold	30,000	–	–	﹤0.01%	129
2018 Q3	$0	Hold	30,000	–	–	﹤0.01%	142
2018 Q2	$0	Buy	+30,000	New	–	﹤0.01%	144

First American Trust's SVNT Position: Q3 2020 in Review

First American Trust sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q3 2020, closing a stake of 30,000 shares.

First American Trust first reported a position in SVNT in Q2 2018 and held it in 9 quarters. The position peaked at $0 in Q2 2020. 0 funds tracked by Wall St. Rank hold SVNT as of Q3 2020.

First American Trust reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q3 2020 after selling out during the quarter.
First American Trust sold 30,000 SAVIENT PHARMACEUTICALS INC shares in Q3 2020.
First American Trust first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2018 and held it in 9 quarters.
First American Trust's SAVIENT PHARMACEUTICALS INC position peaked at $0 in Q2 2020.
0 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q3 2020.

Based on First American Trust's 13F filing for Q3 2020, filed 14 Oct 2020.